Biogen Inc (NASDAQ:BIIB) under-valued by 34%
Website | https://www.biogen.com/ |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2019 |
Market Cap | $36,356,162,000 |
Beta | 0.56693 |
Average Volume | $1,407,932 |
Last Dividend | 0% |
Price on Jul 22, 2020 | $236.26 |
Autochartist™ Valuation | $316.45 |
Conclusion |
34% under-valued |
Download Report |